227 related articles for article (PubMed ID: 28374806)
1. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.
Huang SS; Ding DF; Chen S; Dong CL; Ye XL; Yuan YG; Feng YM; You N; Xu JR; Miao H; You Q; Lu X; Lu YB
Sci Rep; 2017 Apr; 7():45692. PubMed ID: 28374806
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy.
Xu XH; Ding DF; Yong HJ; Dong CL; You N; Ye XL; Pan ML; Ma JH; You Q; Lu YB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4952-4965. PubMed ID: 29164562
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Wang F; Li R; Zhao L; Ma S; Qin G
Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
[TBL] [Abstract][Full Text] [Related]
4. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
[TBL] [Abstract][Full Text] [Related]
5. Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis.
Gu J; Yang M; Qi N; Mei S; Chen J; Song S; Jing Y; Chen M; He L; Sun L; Hu H; Li L; Wüthrich RP; Wu M; Mei C
Kidney Blood Press Res; 2016; 41(6):848-864. PubMed ID: 27871084
[TBL] [Abstract][Full Text] [Related]
6. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
7. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy.
Cao AL; Wang L; Chen X; Wang YM; Guo HJ; Chu S; Liu C; Zhang XM; Peng W
Lab Invest; 2016 Jun; 96(6):610-22. PubMed ID: 26999661
[TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis.
Dong C; Zheng H; Huang S; You N; Xu J; Ye X; Zhu Q; Feng Y; You Q; Miao H; Ding D; Lu Y
Exp Cell Res; 2015 Oct; 337(2):146-59. PubMed ID: 25882498
[TBL] [Abstract][Full Text] [Related]
10. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
Jung E; Kim J; Ho Kim S; Kim S; Cho MH
Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
[TBL] [Abstract][Full Text] [Related]
11. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
13. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
[TBL] [Abstract][Full Text] [Related]
14. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
15. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
16. Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy.
Wu F; Li S; Zhang N; Huang W; Li X; Wang M; Bai D; Han B
Biomed Pharmacother; 2018 Aug; 104():307-314. PubMed ID: 29775899
[TBL] [Abstract][Full Text] [Related]
17. miR-1187 induces podocyte injury and diabetic nephropathy through autophagy.
Chen B; He Q
Diab Vasc Dis Res; 2023; 20(3):14791641231172139. PubMed ID: 37208852
[TBL] [Abstract][Full Text] [Related]
18. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
Sun J; Li ZP; Zhang RQ; Zhang HM
Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
Loeffler I; Rüster C; Franke S; Liebisch M; Wolf G
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F911-8. PubMed ID: 23825071
[TBL] [Abstract][Full Text] [Related]
20. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]